Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004505566 | SCV005002134 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-08-19 | criteria provided, single submitter | clinical testing | The c.78G>A (p.M26I) alteration is located in exon 1 (coding exon 1) of the MSH2 gene. This alteration results from a G to A substitution at nucleotide position 78, causing the methionine (M) at amino acid position 26 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |